Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Galati

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Scandinavian Journal of Gastroenterology|May 7, 2016
The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patientsUmberto Vespasiani-Gentilucci, Paolo Gallo, Aldostefano Porcari, et al.
Clinical Biochemistry|February 28, 2017
Platelet count may impact on lysosomal acid lipase activity determination in dried blood spotUmberto Vespasiani-Gentilucci, Jessica D'Amico, Antonio De Vincentis, et al.
Diagnostics (Basel, Switzerland)|April 13, 2024
Acoustic Radiation Forced Impulse of the Liver and the Spleen, Combined with Spleen Dimension and Platelet Count in New Ratio Scores, Identifies High-Risk Esophageal Varices in Well-Compensated Cirrhotic PatientsAntonio F M Vainieri, Elisa Brando, Antonio De Vincentis, et al.
Clinical and Molecular Hepatology|March 4, 2025
Liver Disease Trends in the Asia-Pacific Region for the Next 50 YearsShuichiro Shiina, Javkhlan Maikhuu, Qing Deng, et al.
Plos One|May 25, 2016
Lysosomal Acid Lipase Activity Is Reduced Both in Cryptogenic Cirrhosis and in Cirrhosis of Known EtiologyUmberto Vespasiani-Gentilucci, Paolo Gallo, Fiorella Piemonte, et al.
The Lancet. Oncology|July 6, 2023
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy conceptAlessandro Vitale, Giuseppe Cabibbo, Massimo Iavarone, et al.
Canadian Journal of Gastroenterology & Hepatology|May 8, 2018
Combining Genetic Variants to Improve Risk Prediction for NAFLD and Its Progression to Cirrhosis: A Proof of Concept StudyUmberto Vespasiani-Gentilucci, Chiara Dell'Unto, Antonio De Vincentis, et al.
Diabetes/Metabolism Research and Reviews|March 10, 2024
Non-invasive assessment of hepatic steatosis by ultrasound-derived fat fraction in individuals at high-risk for metabolic dysfunction-associated steatotic liver diseaseFederica Tavaglione, Valentina Flagiello, Francesca Terracciani, et al.
Journal of Viral Hepatitis|August 17, 2018
Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosisChiara Masetti, Raffaella Lionetti, Marinella Lupo, et al.
Oncology and Therapy|May 20, 2026
Role and Characteristic of Multidisciplinarity in Hepatocellular Carcinoma Management and Care Pathway Certification: Bottom-Up Approach of the MDT Project in ItalyGiuseppe Cabibbo, Caterina Cocuzza, Ciro Celsa, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Scandinavian Journal of Gastroenterology|May 7, 2016
The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patientsUmberto Vespasiani-Gentilucci, Paolo Gallo, Aldostefano Porcari, et al.
Clinical Biochemistry|February 28, 2017
Platelet count may impact on lysosomal acid lipase activity determination in dried blood spotUmberto Vespasiani-Gentilucci, Jessica D'Amico, Antonio De Vincentis, et al.
Diagnostics (Basel, Switzerland)|April 13, 2024
Acoustic Radiation Forced Impulse of the Liver and the Spleen, Combined with Spleen Dimension and Platelet Count in New Ratio Scores, Identifies High-Risk Esophageal Varices in Well-Compensated Cirrhotic PatientsAntonio F M Vainieri, Elisa Brando, Antonio De Vincentis, et al.
Clinical and Molecular Hepatology|March 4, 2025
Liver Disease Trends in the Asia-Pacific Region for the Next 50 YearsShuichiro Shiina, Javkhlan Maikhuu, Qing Deng, et al.
Plos One|May 25, 2016
Lysosomal Acid Lipase Activity Is Reduced Both in Cryptogenic Cirrhosis and in Cirrhosis of Known EtiologyUmberto Vespasiani-Gentilucci, Paolo Gallo, Fiorella Piemonte, et al.
The Lancet. Oncology|July 6, 2023
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy conceptAlessandro Vitale, Giuseppe Cabibbo, Massimo Iavarone, et al.
Canadian Journal of Gastroenterology & Hepatology|May 8, 2018
Combining Genetic Variants to Improve Risk Prediction for NAFLD and Its Progression to Cirrhosis: A Proof of Concept StudyUmberto Vespasiani-Gentilucci, Chiara Dell'Unto, Antonio De Vincentis, et al.
Diabetes/Metabolism Research and Reviews|March 10, 2024
Non-invasive assessment of hepatic steatosis by ultrasound-derived fat fraction in individuals at high-risk for metabolic dysfunction-associated steatotic liver diseaseFederica Tavaglione, Valentina Flagiello, Francesca Terracciani, et al.
Journal of Viral Hepatitis|August 17, 2018
Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosisChiara Masetti, Raffaella Lionetti, Marinella Lupo, et al.
Oncology and Therapy|May 20, 2026
Role and Characteristic of Multidisciplinarity in Hepatocellular Carcinoma Management and Care Pathway Certification: Bottom-Up Approach of the MDT Project in ItalyGiuseppe Cabibbo, Caterina Cocuzza, Ciro Celsa, et al.
Pageof 5